“…Paclitaxel (PTX) is a natural component extracted from the bark of the yew tree, and now it can be semi‐synthesized as an important antineoplastic agent that is a treatment for ovarian cancer, breast cancer and non‐small‐cell lung cancer 1. PTX is poorly soluble, not only in water, but also in the oils and surfactants commonly used to prepare emulsions or other formulations 2–4. Therefore, PTX is formulated for clinical use (Taxol, Bristol‐Myers Squibb Inc., Princeton, NJ, USA) at a concentration of 6 mg/mL in a mixture containing 50% (v/v) of the organic solvent ethanol plus the surfactant polyethoxylated castor oil (Cremophor EL).…”